Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo.
Plug Power achieves certification for its 1 MW stationary system, marking a milestone for green hydrogen expansion amid strategic business priorities and equipment sales focus.
Darden Restaurants reported Q4 results, and increased its dividend. The company also expects same-restaurant sales growth of 1.0% to 2.0% and new restaurant openings of 45 to 50.